Neuroimaging of Opioid Phase (OPAL)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorDuke University
About this trial
The purpose of this study is to compare activity in the brains of female adults with chronic pain and/or opioid use, and healthy female adults that may help to develop new and targeted treatments for adults with chronic pain and alternatives to opioid therapy.
Eligibility criteria
Qualifiers
female and ages 18+
ability to read/understand English and give consent to participate
no current or history of chronic pain
not regularly taking any pain-relieving or mood-altering medications (per PI discretion)
Disqualifiers
limited ability to participate fully in behavioral tasks, longitudinal follow-up
MRI contraindication
any factors that at the discretion of the investigators would adversely affect the participant or the integrity of the study
male
Trial design
Treatments tested in this trial
- Opioid Phase
Treatment groups
140 Participants
are divided into 3 treatment groupsSponsors and collaborators
Duke University
Lead sponsor
National Institutes of Health (NIH)
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov